Deletion 13q14 is a recurring abnormality of Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic lymphoma (SLL). According to current NCCN CLL guidelines, isolated deletions of 13q14 are classified as a favorable cytogenetic risk factor. However, patients with >65% of cells with 13q14 deletions do not do well.
This test can be ordered individually or as either part of a CLL full panel or CLL prognostic panel. See the individual panel tests for more details.
Bone marrow aspirate:
Collect bone marrow aspirate in a sterile Sodium heparin (Na hep) syringe and transfer to a sterile vial/tube
- or -
Transfer aspirate from syringe to transport container.
Submit entire specimen unspun.
Bone Marrow Core:
Submit in sterile tube/cup filled with sterile culture medium, sterile Hanks Balance Salt Solution (HBSS) or sterile saline
or
Whole blood:
Immediately following collection, mix sample thoroughly by gently inverting 8 - 10 times to prevent clotting.
Submit entire specimen unspun
AHL Cytogenetics Oncology Request
Ambient
Fluorescence in situ hybridization (FISH)
Normal or Abnormal with interpretation.